Abstract
Cervicogenic headaches are a significant cause of head and neck pain, and occipital neuralgia is a common component of these cervicogenic headaches. Occipital injections are commonly performed at the occipital ridge, but this site does not address more proximal entrapments of the nerve in the suboccipital region. Because of the potentially dangerous structures in this region, clinicians have tended to avoid the suboccipital region, despite the pathologies seen in this region. This article discusses the pathology of the region, the alternative techniques, and the novel interventional approach developed for this region, specifically the Stealth approach of occipital decompression
Author Contributions
Copyright© 2017
Trescot Andrea, et al.
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Competing interests The authors have declared that no competing interests exist.
Funding Interests:
Citation:
Introduction
Injections of the occipital nerve are common office procedures, perceived as safe, but there have been several devastating complications from occipital injections. In 1978, Selander and Sjöstrand For these reasons, a blunt tipped needle and a suboccipital approach to the occipital nerves was developed. The suboccipital nerve decompression, also known as the Stealth decompression, is a technique using high volume injectate within the suboccipital triangle, used to treat occipital neuralgia. This treatment can be considered as part of a treatment algorithm lying between a superficial occipital nerve block and injection of the dorsal root ganglion of C2. “Headaches” is a term used to describe a wide variety of clinical entities, including intracranial headaches and “migraines”, as well as “tension headaches”, and head pain referred from the neck (“cervicogenic headaches”). A cervicogenic headache (CGH) is defined as a symptomatic unilateral headache with signs and symptoms of neck involvement, such as pain worsened with neck movements and pain with palpation of the neck and/or occipital region The prevalence of CGH is hard to determine, because different studies have used different criteria, and thus the prevalence varies widely, from 0.4% to 80% The largest of the three occipital nerves, the GON, arises from the dorsal root ganglion (DRG) of C2, running inferiorly between the arch of C1 (atlas) and the lamina of C2 (axis), lateral to the lateral atlanto-axial (AA) joint and deep to the inferior oblique capitus (IOC) muscle. The GON then curves medially and cephalad over the IOC -Where the GON emerges from the C2 DRG, between the atlas and axis -Between the IOC and the semispinalis capitis muscles -Where the nerve pierces the semispinalis capitis muscle -Where the GON exits from the aponeurosis of the trapezius The GON can connect with the lesser occipital nerve (LON), which arises from the cervical plexus (formed by the upper four ventral cervical rami), as well as the posterior auricular nerve The GON is prone to trauma from flexion/tension injuries and repetitive neck contractions, which can cause entrapment and/or scarring of the GON, and a head-forward position can entrap the GON at the level of the IOC muscle Occipital neuralgia was first described by Beruto et al.
Discussion
Options for treatment of occipital neuralgia are limited. Occipital nerve blocks are one option, but they are short lived, on the order of 2 weeks. Another common option for occipital neuralgia is the use of botulinum toxin. However, the effect is also short lived, and needs to be repeated every 12 weeks. Radiofrequency lesioning has been used to destroy the occipital nerve, but the pain recurs, there is a risk of neuroma formation Occipital stimulation has also been used effectively to treat intractable headaches, but the systems are expensive (as much as €760,00 or $97,000), with the need for multiple revisions and technical failures. In a 1994 presentation, Umberto Rossi described treating occipital neuralgia by dissecting down to the C1-C2 lamina, cutting the IOC to release the GON, which was flattened and pale. After this release, the nerve became round and pink, suggesting that there is a mechanical compression of the GON by the IOC Suboccipital decompression addresses the underlying pathology of occipital neuralgia, and thus treats the actual entrapment of the greater occipital nerve.
Cited By (6 articles)
This article has been cited by 6 scholarly works according to:
- OpenAlex: 3 citations
- Crossref: 3 citations
- Semantic Scholar: 2 citations
Citing Articles:
Plastic & Reconstructive Surgery (2025) crossref
Samuel A C Knoedler, Konstantin Frank, Thomas Muehlberger, Ali-Farid Safi, S. Cotofana et al. - Plastic and Reconstructive Surgery (2024) semanticscholar
Revista de la Sociedad Española del Dolor (2020) openalex
G. Racz, G. Racz, T. Racz - Pain Management for Clinicians (2020) semanticscholar